ANDA 85779, held by Dr Reddys. Hydroxyzine Hydrochloride.
As of Nov 15, 2026, ANDA 85779 (Hydroxyzine Hydrochloride), held by Dr Reddys, was first approved by FDA on Oct 5, 1979, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 5, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydroxyzine Hydrochloride50MG/ML · injectable;injection | Hydroxyzine Hydrochloride | Discontinued |
| Nov 8, 2016 | Supplement 96Labeling · Standard review | Approved | None posted |
| Mar 30, 2016 | Supplement 95Labeling · Standard review | Approved | None posted |
| Jun 3, 2014 | Supplement 94Labeling · Standard review | Approved | None posted |
| Feb 19, 1999 | Supplement 92Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 91Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 90Manufacturing | Approved | None posted |
| May 23, 1991 | Supplement 89Labeling | Approved | None posted |
| Feb 11, 1991 | Supplement 88Labeling | Approved | None posted |
| Nov 21, 1990 | Supplement 87Manufacturing | Approved | None posted |
| Dec 4, 1989 | Supplement 86Labeling | Approved | None posted |
| Dec 4, 1989 | Supplement 85Labeling | Approved | None posted |
| Aug 3, 1989 | Supplement 84Labeling | Approved | None posted |
| Sep 21, 1988 | Supplement 82Bioequivalence | Approved | None posted |
| Aug 3, 1988 | Supplement 81Manufacturing | Approved | None posted |
| Aug 3, 1988 | Supplement 80Manufacturing | Approved | None posted |
| May 28, 1986 | Supplement 76Manufacturing | Approved | None posted |
| Dec 30, 1983 | Supplement 75Manufacturing | Approved | None posted |
| Feb 8, 1982 | Supplement 73Manufacturing | Approved | None posted |
| Oct 5, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters